The potential associations between MTHFR genotype status and several complications have been evaluated by case–control, cohort, Mendelian randomization, and meta-analysis because formerly it was suggested that reduced enzyme activity of MTHFR led to hyperhomocysteinemia, which amount to an increased risk for venous thromboembolism, coronary heart disease, and recurrent pregnancy loss (166). Here, MTHFR is linked to venous thromboembolism.